Vericel Corporation

VCEL

$30.55

Name : Vericel Corporation

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,555,960,320.00

EPSttm : 0.32

Vericel Corporation

$30.55

4.12%

$1.21

VCEL — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

10.04

Margin Of Safety %

-8

Put/Call OI Ratio

1.97

EPS Next Q Diff

-0.43

EPS Last/This Y

0.08

EPS This/Next Y

0.35

Price

30.57

Target Price

55.43

Analyst Recom

1.25

Performance Q

-18.88

Upside

-64.5%

Beta

1.25

Ticker: VCEL

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	VCEL	35.33	0.45	999.99	677
2026-03-03	VCEL	34.38	0.45	0.20	679
2026-03-04	VCEL	34.94	0.46	0.00	681
2026-03-05	VCEL	34.03	0.46	0.00	681
2026-03-06	VCEL	33.7	0.52	0.00	627
2026-03-09	VCEL	34.11	0.52	999.99	627
2026-03-10	VCEL	33.39	0.55	1.00	641
2026-03-11	VCEL	32.89	0.55	0.67	641
2026-03-12	VCEL	32.12	0.56	0.00	643
2026-03-13	VCEL	32.11	0.56	0.00	643
2026-03-17	VCEL	32.5	0.56	2.00	637
2026-03-18	VCEL	32.58	0.53	0.00	658
2026-03-19	VCEL	32.73	0.53	0.00	659
2026-03-20	VCEL	31.42	0.51	999.99	654
2026-03-23	VCEL	32.44	0.51	999.99	654
2026-03-24	VCEL	33.12	1.07	0.00	413
2026-03-25	VCEL	31.46	1.04	2.00	418
2026-03-26	VCEL	30.82	1.97	0.20	22925
2026-03-27	VCEL	29.33	1.97	0.00	22926
2026-03-30	VCEL	30.55	1.97	0.00	22926
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	VCEL	35.39	0.5	-	0.26
2026-03-03	VCEL	34.41	33.9	-	0.41
2026-03-04	VCEL	34.91	33.9	-	0.41
2026-03-05	VCEL	34.03	33.9	-	0.41
2026-03-06	VCEL	33.70	33.9	-	0.41
2026-03-09	VCEL	34.17	33.9	-	0.41
2026-03-10	VCEL	33.39	33.9	-	0.41
2026-03-11	VCEL	32.90	33.9	-	0.41
2026-03-12	VCEL	32.13	33.9	-	0.41
2026-03-13	VCEL	32.53	33.9	-	0.41
2026-03-17	VCEL	32.53	33.9	-	0.41
2026-03-18	VCEL	32.31	33.9	-	0.41
2026-03-19	VCEL	32.74	33.9	-	0.41
2026-03-20	VCEL	31.44	33.9	-	0.41
2026-03-23	VCEL	32.42	33.9	-	0.41
2026-03-24	VCEL	33.10	33.9	-	0.41
2026-03-25	VCEL	31.45	33.9	-	0.41
2026-03-26	VCEL	30.81	33.9	-	0.41
2026-03-27	VCEL	29.36	33.9	-	0.41
2026-03-30	VCEL	30.57	33.9	-	0.41
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	VCEL	-7.92	-0.33	9.56
2026-03-03	VCEL	-7.92	-0.33	9.56
2026-03-04	VCEL	-10.95	-0.33	9.56
2026-03-05	VCEL	-10.95	-0.33	9.56
2026-03-06	VCEL	-10.95	-0.33	9.56
2026-03-09	VCEL	-10.95	-0.33	9.56
2026-03-10	VCEL	-10.95	-0.33	9.56
2026-03-11	VCEL	-10.95	-0.33	9.56
2026-03-12	VCEL	-10.95	-0.33	9.56
2026-03-13	VCEL	-10.95	-0.33	9.56
2026-03-17	VCEL	-10.95	-0.33	9.56
2026-03-18	VCEL	-10.95	-0.33	9.56
2026-03-19	VCEL	-10.95	-0.33	9.56
2026-03-20	VCEL	-10.95	-0.33	9.56
2026-03-23	VCEL	-10.95	-0.32	9.56
2026-03-24	VCEL	-10.95	-0.32	9.56
2026-03-25	VCEL	-12.92	-0.32	10.04
2026-03-26	VCEL	-12.92	-0.32	10.04
2026-03-27	VCEL	-12.92	-0.32	10.04
2026-03-30	VCEL	-12.92	-0.32	10.04
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.45

Avg. EPS Est. Current Quarter

-0.15

Avg. EPS Est. Next Quarter

0.02

Insider Transactions

-12.92

Institutional Transactions

-0.32

Beta

1.25

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

28.09

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

55.7

Max Drawdown 5-Year %

-74

Target Price

55.43

P/E

99.25

Forward P/E

38.61

PEG

0.65

P/S

5.61

P/B

4.36

P/Free Cash Flow

62.66

EPS

0.31

Average EPS Est. Cur. Y

0.41

EPS Next Y. (Est.)

0.76

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.98

Relative Volume

1.63

Return on Equity vs Sector %

-22.8

Return on Equity vs Industry %

-6.5

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.17

EBIT Estimation

◆ VCEL Healthcare

$30.55

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

16/25

Volume

3/15

Valuation

15/20

TP/AR

4/10

Options

1/10

RSI

37.7

Range 1M

22.6%

Sup Dist

6.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

11/25

Growth

23/30

Estimates

10/20

Inst/Vol

3/15

Options

1/10

EPS Yr

35.2%

EPS NY

83%

52W%

9.5%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +7.4% upside

Quality

8/30

Valuation

5/30

Growth

20/25

Stability

7/10

LT Trend

4/5

Upside

+7.4%

Quality

MoS

-8%

Vericel Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 398

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

VCEL

Latest News

—

Caricamento notizie per VCEL…

stock quote shares VCEL – Vericel Corporation Stock Price stock today

news today VCEL – Vericel Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch VCEL – Vericel Corporation yahoo finance google finance

stock history VCEL – Vericel Corporation invest stock market

stock prices VCEL premarket after hours

ticker VCEL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VCEL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y